Psychiatry related information on Geriatric Psychiatry

• 1995 IPA/Bayer Research Awards in Psychogeriatrics. Reclassification of the vascular dementias: comparisons of infarct and noninfarct vascular dementias [1].

High impact information on Geriatric Psychiatry

• Sixty-five percent first developed interest in geriatric psychiatry during their residency years (the majority during their PGY1 or PGY2 year) [2].
• Uses of intravenous valproate in geriatric psychiatry [3].
• Of the original cohort, 72.5% were contacted, and two subgroups were defined: 31 patients were being seen only by their primary care physicians (MED), and 27 patients were being treated in addition by a geriatric psychiatry faculty member (GERO) [4].
• All patients admitted to the neuropsychiatry or geriatric psychiatry inpatient units of Johns Hopkins Hospital in 2000 and 2001 who were treated empirically with amantadine for executive dysfunction syndrome were included in the review [5].
• SARS and psychogeriatrics: perspective and lessons from Hong Kong [6].

Associations of Geriatric Psychiatry with chemical compounds

• Gabapentin in geriatric psychiatry patients [7].
• In conclusion, electrophysiological studies with the psychogeriatrics oxiracetam and piracetam revealed that the drugs exert weak effects on rat brain tissue in acute experiments, and demonstrated that the two compounds differ in their pharmacological profile [8].
• The objective of this study was to assess benzodiazepine use and the treatment of depression before admission to an inpatient geriatric psychiatry unit in a sample of elderly patients [9].

Gene context of Geriatric Psychiatry

• BACKGROUND: The genetically polymorphic cytochrome P450 2D6 isozyme (CYP2D6) is responsible for the metabolism of numerous psychotropic medications pertinent to the practice of geriatric psychiatry [10].
• The 1991 IPA Research Awards in Psychogeriatrics [11].
• Validation of the Geriatric Psychiatry Knowledge Test [12].

References